Adam Neumann: This is How You Build Iconic Companies
a16z Podcast16 Kesä

Adam Neumann: This is How You Build Iconic Companies

In this recent episode of The Ben & Marc Show, a16z co-founders Marc Andreessen and Ben Horowitz sit down with Adam Neumann—founder of WeWork and now Flow—to unpack one of the most unlikely comeback storie s in tech.

What began as a personal reckoning after a very public fall has become a bold new vision for how we live and belong. Flow isn’t just a real estate company—it’s an operating system for community, built on first-principles software, design, and soul.

Joined by a16z General Partner Erik Torenberg, the group goes deep on:

  • Why Adam’s childhood shaped his obsession with community
  • Adam’s fall from WeWork—and how he found a new path to redemption
  • How Flow is re-architecting real estate from scratch
  • Why loneliness is the greatest design challenge of our time

With reflections on dyslexia, the American dream, and the thin line between failure and greatness, this is a candid and wide-ranging conversation about redemption, vision, and building something that matters in this world. We hope you enjoy this deeply human conversation about the future of living.

Timecodes

00:00 Introduction

00:51 Adam's Early Life and Family Background

07:56 Military Service and Discipline

10:08 Transition to the US and Education

14:43 Entrepreneurial Journey Begins

17:49 The Concept of Flow and Vision

20:28 Meeting and Partnership Formation

25:22 Overcoming Challenges and Resilience

28:30 The Isolation Phenomenon

30:03 Navigating Post-Crisis Relationships

31:50 Real Estate Strategies During COVID

33:47 The Genesis of a New Venture

36:47 Lessons from WeWork

38:49 Building Flow: The Vision

41:44 The Importance of Alignment

51:23 Technological Innovations in Real Estate

55:44 Revolutionizing Real Estate Software and Flexible Living Solutions

56:28 Challenges and Innovations in Multifamily Housing Rental Markets

58:40 Global Housing Crisis and Solutions

01:06:10 Expanding to Saudi Arabia

01:08:49 Success in Saudi Arabia

01:12:43 Real Estate Funds and Future Plans

01:19:10: Why Is This an Opportunity?

01:20:45 Impact of COVID on Living and Working

01:26:14 Future Potential of Housing and Living

Resources:

Read Marc's blog post about Flow: https://a16z.com/announcement/flow/

Marc on X: https://x.com/pmarca

Marc’s Substack: https://pmarca.substack.com/

Ben on X: https://x.com/bhorowitz

Erik on X: https://x.com/eriktorenberg

Erik's Substack: https://eriktorenberg.substack.com/

Stay Updated:

Let us know what you think: https://ratethispodcast.com/a16z

Find a16z on Twitter: https://twitter.com/a16z

Find a16z on LinkedIn: https://www.linkedin.com/company/a16z

Subscribe on your favorite podcast app: https://a16z.simplecast.com/

Follow our host: https://x.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.

Jaksot(918)

Undruggable Drugs

Undruggable Drugs

In this episode of the a16z Podcast, we take a deep dive into the world of drug development—specifically "undruggable drugs": a category of protein, protein family or even piece of RNA that’s so difficult to target that many researchers don’t even want to touch it. Jay Bradner, President of the Novartis Institute for BioMedical Research, shares with a16z General Partners Jorge Conde and Vijay Pande, and a16z's Hanne Tidnam, all the new tools, technologies and breakthroughs which are causing the science of therapeutics to explode in some of these areas where it's been incredibly difficult (even impossible) in the past. From molecular glues to cell and gene therapies, Bradner shares the behind-the-scenes science stories of what it really takes to make a new drug that shatters the category of an "undruggable" target.

6 Touko 202028min

The Next Generation of Cultural Influencers in Tech

The Next Generation of Cultural Influencers in Tech

This episode—which originally took place as a live event—is a conversation between Seattle Seahawks linebacker Bobby Wagner and a16z Cultural Leadership Fund partner Chris Lyons. Wagner is known for his power on the field and his business acumen off it. Last year, he negotiated his own three-year, $54 million contract extension to become the highest-paid middle linebacker in the NFL. In this candid conversation, Wagner and Lyons discuss how to identify standout companies and talent (for better or worse), the growing influence of cultural leaders in tech, and the potential of "shared genius."

2 Touko 202013min

The Chief Security Officer in (and out of) a Crisis

The Chief Security Officer in (and out of) a Crisis

The Chief Security Officer (CSO/CISO) used to manage on-premise servers, now the information they have to secure has migrated to the cloud. As the responsibility of CSOs has expanded, the role has moved from technical IT to the boardroom. How do the best CSOs prepare for and respond to a crisis, from redteaming to comms? What responsibility should cloud & SaaS vendors, not to mention the government, have in security and data breaches?  And how is the role going to evolve in the next five years? At our a16z Innovation Summit last year, we sat down with two security leaders whose career has evolved as the role has – Joe Sullivan, former CSO at Uber and Facebook, now at Cloudflare and Joel de la Garza, current security partner at a16z, formerly CISO at Box.

29 Huhti 202020min

Journal Club: Finding New Antibiotics with Machine Learning, What Coronavirus Structures Tell Us

Journal Club: Finding New Antibiotics with Machine Learning, What Coronavirus Structures Tell Us

a16z Journal Club (part of the a16z Podcast), curates and covers recent advances from the scientific literature -- what papers we’re reading, and why they matter from our perspective at the intersection of biology & technology (for bio journal club). This inaugural episode covers 2 different topics, in discussion with Lauren Richardson:0:26 #1 identifying new antibiotics through a novel machine-learning based approach -- a16z general partner Vijay Pande and bio deal partner Andy Tran discuss the business of pharma; the specific methods/  how it works; and other applications for deep learning in drug discovery and development based on this paper:"A Deep Learning Approach to Antibiotic Discovery" in Cell (February 2020), by Jonathan Stokes, Kevin Yang, Kyle Swanson, Wengong Jin, Andres Cubillos-Ruiz, Nina Donghia, Craig MacNair, Shawn French, Lindsey Carfrae, Zohar Bloom-Ackermann, Victoria Tran, Anush Chiappino-Pepe, Ahmed Badran, Ian Andrews, Emma Chory, George Church, Eric Brown, Tommi Jaakkola, Regina Barzilay, James Collins11:43 #2 characterizing the novel coronavirus causing the COVID-19 pandemic -- a16z bio deal partner Judy Savitskaya shares what we can learn from the protein structures; the relationship to the 2002-2004 SARS epidemic; and more based on these two research articles: "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein" in Cell (April 2020), by Alexandra Walls, Young-Jun Park, M. Tortorici, Abigail Wall, Andrew McGuire, David Veesler"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation" in Science (March 2020), by Daniel Wrapp, Nianshuang Wang, Kizzmekia Corbett, Jory Goldsmith, Ching-Lin Hsieh, Olubukola Abiona, Barney Graham, Jason McLellanYou can find these episodes at a16z.com/journalclub.

26 Huhti 202024min

Introducing Journal Club

Introducing Journal Club

Announcing a16z Journal Club, a new show where we curate and discuss recent research papers with a16z experts and others. This new show continues the a16z Podcast mission of not just bringing you conversations about the future (as well as about building companies for this), but of also putting specific trends in context -- whether through news (as with our other show 16 Minutes), or, through journal articles (as with this new show -- which will soon have its own feed as well). The first episode, of bio journal club, focuses on why specific scientific advances matter from our perspective at the intersection of biology & technology. It is hosted by one of our a16z bio editors, Lauren Richardson, a former senior editor of open-access journal PLOS Biology with a background in cell and molecular biology and genetics (and with a Ph.D. from the University of Washington and a postdoctoral fellowship at UC Berkeley).You will hear it next in this feed, and can also find new episodes here as they come out every few weeks and at a16z.com/journalclub. ~sonal

26 Huhti 20201min

What the Narrow Waist of the Internet Means for Innovation Today

What the Narrow Waist of the Internet Means for Innovation Today

Here is Ali's tweetstorm on the Narrow Waist of Blockchain Computing

24 Huhti 202040min

IT'S TIME TO BUILD

IT'S TIME TO BUILD

“It's Time to Build” by Marc Andreessen. You can also find and share this essay at a16z.com/build

21 Huhti 202012min

Introducing Read Alouds

Introducing Read Alouds

We wanted to let you know about a special new series of posts occasionally read out loud from us  (you can learn more about the why and why now in episode #500 on how we podcast); we may release these in a separate feed in future, for now, the first episode is next in this feed. Thank you for listening!You can also check out our other shows and series:16 MinutesHustlin' Tech

21 Huhti 202033s

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
puheenaihe
rss-rahapodi
ostan-asuntoja-podcast
rss-rahamania
rss-startup-ministerio
rss-seuraava-potilas
pomojen-suusta
hyva-paha-johtaminen
rss-lahtijat
oppimisen-psykologia
rss-paasipodi
herrasmieshakkerit
rss-bisnesta-bebeja
taloudellinen-mielenrauha
rahapuhetta
rss-wtf-markkinointi-by-dagmar
camilla-tuominen-podcast